Fluoxetine in the Treatment of Premenstrual Dysphoria

We performed a double-blind, placebo-controlled, crossover trial of fluoxetine in 17 women with prospectively confirmed PMS who also met criteria for premenstrual dysphoric disorder (PMDD). A subset of 10 women with PMDD and an additional 10 controls participated in a single-dose m-chlorophenylpiper...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 1997-05, Vol.16 (5), p.346-356
Hauptverfasser:	Su, Tung-Ping, Schmidt, Peter J, Danaceau, Merry A, Tobin, Marie B, Rosenstein, Donald L, Murphy, Dennis L, Rubinow, David R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressive Agents, Second-Generation - therapeutic use Behavioral Sciences Biological and medical sciences Biological Psychology Double-Blind Method Female Fluoxetine - therapeutic use Humans Medical sciences Medicine Medicine & Public Health Middle Aged Neuropharmacology Neurosciences original-article Personality Inventory Pharmacology. Drug treatments Pharmacotherapy Piperazines - pharmacology Premenstrual Syndrome - drug therapy Prospective Studies Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Self-Assessment Serotonin Receptor Agonists - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!